Roche explores quantum computing applications for pharmaceutical research and drug discovery, investigating quantum algorithms for molecular simulation, protein folding prediction, and drug-target interaction modeling that could accelerate the development of new medicines and personalized therapies, collaborating with quantum computing companies and research institutions to leverage quantum advantages in computational chemistry, clinical trial optimization, and biomarker discovery, exploring how quantum machine learning and quantum simulation could enhance pharmaceutical research capabilities and reduce drug development timelines while improving therapeutic outcomes for patients across oncology, immunology, and other therapeutic areas.
Explore other quantum computing companies in similar categories or regions.